# OnCo record rainbow (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/rainbow/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "rainbow", "NCT01170663" ;
  schema:name "RAINBOW"@en ;
  schema:description "Made ramucirumab plus paclitaxel the standard second-line stomach cancer treatment, a role it held for a decade until Enhertu and Claudin drugs arrived."@en ;
  schema:url <https://onco.cc/trials/rainbow/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT01170663> ;
  onco:status "positive" ;
  onco:phase "3" ;
  schema:startDate "2010-12" ;
  onco:cancers <https://onco.cc/cancers/gastric/> ;
  onco:technologies <https://onco.cc/technologies/antiangiogenic/>, <https://onco.cc/technologies/monoclonal-antibody/> ;
  onco:targets <https://onco.cc/targets/vegf/> ;
  onco:drugs <https://onco.cc/drugs/ramucirumab/>, <https://onco.cc/drugs/paclitaxel/> ;
  onco:companies <https://onco.cc/companies/eli-lilly/> ;
  onco:people <https://onco.cc/people/ryu-min-hee/> .